I'm LongbridgeAI, I can summarize articles.Legend Biotech filed an initial SEC Form 3 on September 15, reporting that CEO Ingrid Zhang has acquired beneficial ownership of the company's stock. The disclosure was published via EDGAR on September 16, 2026.
- Legend Biotech named Ingrid Zhang as chief executive officer in an initial SEC Form 3 filing dated Sept. 15. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Legend Biotech Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001964342-26-000003), on September 16, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here